Kazuo Notsumata Selected Research

Kazuo Notsumata Research Topics

Disease

10	Neoplasms (Cancer) 12/2021 - 09/2003
8	Fibrosis (Cirrhosis) 10/2022 - 02/2006
4	Infections 10/2022 - 05/2015
3	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 11/2004
3	Liver Diseases (Liver Disease) 07/2019 - 07/2012
2	Chronic Hepatitis C 10/2022 - 07/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 07/2020 - 01/2020
2	Necrosis 04/2009 - 11/2007
1	Fever (Fevers) 03/2022
1	Polycystic liver disease 03/2022
1	Pain (Aches) 03/2022
1	Cysts 03/2022
1	Liver Neoplasms (Liver Cancer) 12/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2020
1	Lymphoma (Lymphomas) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Hepatitis 01/2020
1	Hepatitis B 01/2020
1	Hepatitis C 01/2020
1	Multiple Myeloma 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Thrombocytopenia (Thrombopenia) 07/2019
1	Headache (Headaches) 07/2019
1	Vomiting 07/2019
1	Thrombosis (Thrombus) 02/2018
1	Inflammation (Inflammations) 07/2012
1	Alcoholic Fatty Liver 07/2012
1	Non-alcoholic Fatty Liver Disease 07/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2012
1	Jaundice (Icterus) 12/2010
1	Autoimmune Hepatitis 11/2007
1	Sialadenitis 02/2006
1	Autoimmune Pancreatitis 02/2006
1	Mediastinal Fibrosis 02/2006
1	Pancreatitis 02/2006

Drug/Important Bio-Agent (IBA)

5	Antiviral Agents (Antivirals)IBA 01/2020 - 05/2015
4	Iodized OilIBA 12/2017 - 09/2003
2	Immunoglobulin G (IgG)IBA 01/2020 - 02/2006
2	SteroidsIBA 01/2020 - 02/2006
2	P-300IBA 08/2019 - 01/2018
2	glecaprevir and pibrentasvirIBA 08/2019 - 01/2018
2	Ribavirin (Virazole)FDA LinkGeneric 07/2019 - 01/2018
2	InterferonsIBA 07/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2018
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2018 - 05/2015
1	SofosbuvirIBA 10/2022
1	velpatasvirIBA 10/2022
1	Peptide Hydrolases (Proteases)FDA Link 10/2022
1	ethanolamine oleate (Ethamolin)FDA Link 03/2022
1	1-dodecylpyridoxal (PLD)IBA 03/2022
1	Phosphotransferases (Kinase)IBA 07/2020
1	MineralsIBA 07/2020
1	CC ChemokinesIBA 07/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020
1	Sodium-Glucose Transport ProteinsIBA 07/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2020
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Bortezomib (Velcade)FDA Link 01/2020
1	AntigensIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Vitamin K FDA Link 07/2019
1	eltrombopag FDA Link 07/2019
1	Antithrombin IIIIBA 02/2018
1	pibrentasvirIBA 01/2018
1	glecaprevirIBA 01/2018
1	ombitasvirIBA 05/2015
1	paritaprevirIBA 05/2015
1	Ritonavir (Norvir)FDA Link 05/2015
1	Indicators and Reagents (Reagents)IBA 07/2012
1	AlbuminsIBA 07/2012
1	Alanine Transaminase (SGPT)IBA 07/2012
1	Fluconazole (Zonal)FDA LinkGeneric 11/2007
1	Antinuclear AntibodiesIBA 11/2007
1	GelatinIBA 01/2006
1	Coloring Agents (Dyes)IBA 09/2003

Therapy/Procedure

3	Catheters 03/2022 - 11/2004
2	Radiofrequency Ablation 12/2021 - 04/2009
2	Therapeutics 07/2019 - 09/2003
1	Sclerotherapy 03/2022
1	Transplantation 12/2021
1	Liver Transplantation 07/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Stents 12/2010
1	Aftercare (After-Treatment) 08/2010
1	Hepatectomy 04/2009
1	Cholecystectomy 09/2003